Bio-Path Holdings, Inc.
(NASDAQ : BPTH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
0.14%46.498.1%$739.63m
AMGNAmgen Inc.
0.36%176.761.3%$505.43m
CELGCelgene Corporation
0.08%91.831.3%$444.53m
GILDGilead Sciences, Inc.
-1.50%67.050.9%$405.30m
BIIBBiogen Inc.
-0.26%233.011.3%$386.66m
ILMNIllumina, Inc.
0.07%302.493.5%$336.00m
REGNRegeneron Pharmaceuticals, Inc.
-0.11%297.882.6%$277.86m
SRPTSarepta Therapeutics, Inc.
-2.62%152.8014.7%$203.40m
ALXNAlexion Pharmaceuticals, Inc.
0.72%123.922.0%$199.57m
VRTXVertex Pharmaceuticals Incorporated
0.22%176.761.9%$187.90m
EXASExact Sciences Corporation
-0.41%115.7124.1%$139.91m
AAgilent Technologies, Inc.
-0.91%69.911.6%$134.04m
INCYIncyte Corporation
-1.36%80.282.5%$114.51m
BLUEBluebird Bio, Inc.
-1.38%133.8814.3%$97.84m
BMRNBioMarin Pharmaceutical Inc.
-1.76%82.514.3%$87.79m

Company Profile

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.